Procter & Gamble Health Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Jun ' 24	Jun ' 23	Jun ' 22	Jun ' 21	Jun ' 20

Sources of funds

Owner's fund

Equity share capital

16.60

16.60

16.60

16.60

16.60

Share application money

8.53

7.84

7.28

3.87

1.94

Preference share capital

-

-

-

-

-

Reserves & surplus

513.11

726.45

592.61

683.24

887.80

Loan funds

Secured loans

-

-

-

-

-

Unsecured loans

-

-

-

-

-

Total

538.24

750.89

616.49

703.71

906.34

Uses of funds

Fixed assets

Gross block

219.57

262.04

242.11

216.35

201.50

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

91.07

118.07

130.45

112.44

100.28

Net block

128.50

143.97

111.66

103.91

101.22

Capital work-in-progress

5.89

32.49

40.60

39.15

21.45

Investments

-

-

-

-

-

Net current assets

Current assets, loans & advances

659.97

924.73

741.46

843.10

1,053.07

Less : current liabilities & provisions

256.12

350.30

277.23

282.45

269.40

Total net current assets

403.85

574.43

464.23

560.65

783.67

Miscellaneous expenses not written

-

-

-

-

-

Total

538.24

750.89

616.49

703.71

906.34

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

165.89

165.48

258.16

244.23

194.70

Number of equity sharesoutstanding (Lacs)

165.99

165.99

165.99

165.99

165.99